[Burkitt's lymphoma--a case report]

Praxis (Bern 1994). 1999 Sep 2;88(36):1444-8.
[Article in German]

Abstract

Burkitt-lymphoma is a rare disease, that belongs to the aggressive Non-Hodgkin-lymphomas. Next to histology, that shows a characteristic pattern, and immunophenotyping additional cytogenetic and molecular biology techniques are used to demonstrate in most cases a translocation of the oncogen c-myc on chromosome 8 to any of the immunoglobulin genes on chromosome 14, 2 or 22. With short term intensive chemotherapies a cure rate of 85-95% of patients with Burkitt-lymphoma can be obtained today.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols
  • Bleomycin / therapeutic use
  • Burkitt Lymphoma / diagnosis*
  • Burkitt Lymphoma / drug therapy*
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Diagnosis, Differential
  • Epirubicin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Methotrexate / therapeutic use
  • Prednisone / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Cytarabine
  • Bleomycin
  • Epirubicin
  • Vincristine
  • Etoposide
  • Cyclophosphamide
  • Prednisone
  • Methotrexate

Supplementary concepts

  • ProMECE-CytaBOM protocol